Birgit Luber

3PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 27, 2022
Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.

Katharina Kolbe, Ivonne Haffner, Katrin Schierle

|Mar 03, 2020
Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines.

Elba Raimúndez, Simone Keller, Gwen Zwingenberger

|Dec 10, 2016
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Julia Kneissl, Anja Hartmann, Nicole Pfarr

Pageof 1